GlassScriptPhysician profile
Thomas R Lake
NPI 1003881277
$15,477.82
in general payments reported to CMS, 2019-2025
34 companies · $685 in 2025
The $685 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $65.48 · 2021: $5,019 · 2022: $1,631 · 2023: $4,970 · 2024: $3,007 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,881 · Consulting Fee: $2,000 · Travel and Lodging: $1,281 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,880.79 |
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $1,281.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $5,029.57 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $4,765.97 | 2021-2024 | Da Vinci Sp |
| Integra Lifesciences Corporation | $2,479.11 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Davol INC. | $772.54 | 2020-2025 | Channel Drain, Phasix Mesh |
| W. L. Gore & Associates, INC. | $627.85 | 2024-2025 | Gore Synecor Biomaterial, Gore Enform Intraperitoneal Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Dilon Technologies, INC. | $517.91 | 2023-2024 | Hemoblast Bellows |
| Stryker Corporation | $184.43 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $118.97 | 2024-2025 | |
| Innovation Technologies INC | $107.01 | 2021 | |
| Kerecis Limited | $84.68 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Kowa Pharmaceuticals America, INC. | $84.40 | 2022-2023 | Seglentis |
| Smith+Nephew, INC. | $71.87 | 2019-2024 | Renasys Go V2 Home |
| Pacira Pharmaceuticals Incorporated | $61.54 | 2019-2024 | Exparel, Iovera |
| Takeda Pharmaceuticals U.S.A., INC. | $60.37 | 2021-2025 | Gattex |
| Ethicon US, LLC | $57.50 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $48.59 | 2022-2024 | Solesta |
| Conmed Corporation | $44.05 | 2025 | Airseal |
| Boston Scientific Corporation | $40.26 | 2022-2025 | Axonics |
| Medtronic, INC. | $33.75 | 2021 | |
| Innocoll Pharmaceuticals Limited | $32.73 | 2021 | |
| Baxter Healthcare | $30.82 | 2024 | Floseal |
| Olympus America INC. | $30.55 | 2021 | |
| Sanara Medtech INC. | $23.66 | 2024 | Celleraterx |
| Merck Sharp & Dohme LLC | $21.88 | 2024 | Bridion |
| Acera Surgical, INC. | $20.32 | 2025 | Restrata Wound Matrix |
| Allergan, INC. | $19.51 | 2019 | |
| Bioventus LLC | $17.49 | 2022 | |
| Solventum Corporation | $16.35 | 2024 | Abthera, V.A.C.Ulta |
| Axonics, INC. | $14.33 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.24 | 2019 | |
| Coloplast Corp | $12.53 | 2022 | |
| Misonix INC | $12.51 | 2021 | |
| Braintree Laboratories, INC. | $12.45 | 2020 | |
| Thd America, INC. | $8.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.